Skip to content

Determination of the Effects of Change in Anxiety Level on Pain Perception in Patients Who Present to Emergency Department

Determination of the Effects of Change in Anxiety Level on Pain Perception in Patients Who Present to Emergency Department Due to Acute Pain: a Double Blind, Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03420911
Enrollment
180
Registered
2018-02-05
Start date
2013-06-30
Completion date
2013-12-31
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute, Anxiety

Keywords

pain, anxiety, emergency department, pain management

Brief summary

The aim of this study is to determine the level of pain and anxiety in patients who present to the emergency department with acute pain, and to investigate the effect of the standard analgesic treatment and an additional anxiolytic treatment on pain and anxiety.

Detailed description

After triage, each acute pain patient who qualified for the study was asked for consent. Written informed consent was obtained from all patients who were eligible for the study. After obtaining written informed consent, demographic and clinical data were collected and recorded by the attending physician. Our study consisted of two parallel groups. Participants were randomly assigned into two groups with a 1:1 allocation following simple randomization procedures by a program generating an online random number. The control group was given only the analgesic drug dexketoprofen trometamol and the study group was given analgesic plus anxiolytic, the same dose of dexketoprofen trometamol plus midazolam . Both groups received the study drugs in 100 mL of normal saline within 5 minutes. The dexketoprofen trometamol dose was 50 mg, and the midazolam dose was 1 mg. The study was double-blind. Sequenced study medications were prepared by a nurse, and another nurse administered the medications. In patients with an insufficient improvement of pain after 60 minutes, fentanyl 1 mcg/kg ı.v. was administered as a rescue medication. Pain and anxiety in patients was measured at 0, 30, 60 and 120 minutes using the standard 100 mm horizontal visual analogue scale (VAS). The patient's general anxiety states were measured with the Turkish adopted version of the Hospital Anxiety and Depression Scale (HADS). Patients who have greater than 10 points are assumed anxious (9). The HADS and VAS scores were measured and recorded to the database by the researcher. At the time of discharge, patient satisfaction with treatment was evaluated by asking two questions with the 5-step Likert scale. The questions were, I am satisfied with the applied treatment, and I would like the same treatment applied again. Patient answers were, 1-I strongly disagree, 2-I disagree, 3-I am not sure, 4-I agree, and 5-I strongly agree.

Interventions

DRUGMidazolam

Sponsors

Derince Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Sequenced study medications were prepared by a nurse, and another nurse administered the medications.

Intervention model description

Participants were randomly assigned into two groups with a 1:1 allocation following simple randomization procedures by a program generating an online random number

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patients who presented to the emergency department with acute pain * Who accepted to include the study * Who were older than 18 years old

Exclusion criteria

* Patients who refused to participate to the study * History of allergy to any of the study drugs * Pregnancy * Younger than 18 years old * Chronic pain * Antidepressant or anxiolytic drug use * Advanced kidney or liver failure * Use of analgesics within 6 hours before presentation

Design outcomes

Primary

MeasureTime frameDescription
the change in anxiety levels30 minutesthe change in anxiety levels between groups on the 100mm visual analogue scale at 0-30th minutes
the change in pain levels30 minutesthe change in pain levels between groups on the 100mm visual analogue scale at 0-30th minutes

Secondary

MeasureTime frameDescription
the need for rescue treatment120 minutesthe need for rescue treatment at 60th minute and at 120 th minute
the rate of the request for the same treatment120 minutesthe rate of the request for the same treatment again on the Likert scale
the comparison of the pain and anxiety change on the visual analogue scale120 minutesthe comparison of the pain and anxiety change on the visual analogue scale in patients who have a greater anxiety score.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026